Alnylam Pharmaceuticals
ALNY
#601
Rank
S$44.47 B
Marketcap
$343.59
Share price
-5.28%
Change (1 day)
65.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company